Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

Timothy M. ZagarDepartment of Radiation Oncology, University of North Carolina Hospital Chapel HillNorth Carolina

Zeljko VujaskovicDepartment of Radiation Oncology, University of Maryland Medical Center BaltimoreMaryland

Silvia FormentiDepartment of Radiation Oncology, New York University Langone Medical CenterNew York

Hope RugoDepartment of Medicine, University of California San Francisco Helen Diller Family Cancer Center San FranciscoCalifornia

Franco MuggiaDepartment of Medicine, New York University Langone Medical CenterNew YorkCorrespondence[email protected]

Brigid O’ConnorDepartment of Radiation Oncology, Rhode Island Hospital ProvidenceRhode Island

Robert MyersonDepartment of Radiation Oncology, Washington University at St. Louis Siteman Cancer Center St. LouisMissouri

Paul StaufferDepartment of Radiation Oncology, Duke University Medical Center DurhamNorth Carolina

I-Chow HsuDepartment of Radiation Oncology, University of California San Francisco Helen Diller Family Cancer Center San FranciscoCalifornia

Chris DiederichDepartment of Radiation Oncology, University of California San Francisco Helen Diller Family Cancer Center San FranciscoCalifornia

William StraubeDepartment of Radiation Oncology, Washington University at St. Louis Siteman Cancer Center St. LouisMissouri

Mary-Keara BossDepartment of Molecular Biomedical Sciences, North Carolina State College of Veterinary Medicine RaleighNorth Carolina

Alina BoicoDepartment of Radiation Oncology, Duke University Medical Center DurhamNorth Carolina

Oana CraciunescuDepartment of Radiation Oncology, Duke University Medical Center DurhamNorth Carolina

Paolo MaccariniDepartment of Biomedical Engineering, Duke University DurhamNorth Carolina

David NeedhamDepartment of Mechanical Engineering and Material Science, Duke University Medical Center DurhamNorth Carolina

Nicholas BorysCelsion Corporation LawrencevilleNew Jersey

Kimberly L. BlackwellDepartment of Medicine, Duke University Medical Center Durham, North CarolinaUSA

Mark W. DewhirstDepartment of Radiation Oncology, Duke University Medical Center DurhamNorth CarolinaCorrespondence[email protected]

Your download is now in progress and you may close this window